271 related articles for article (PubMed ID: 29504907)
1. HK3 overexpression associated with epithelial-mesenchymal transition in colorectal cancer.
Pudova EA; Kudryavtseva AV; Fedorova MS; Zaretsky AR; Shcherbo DS; Lukyanova EN; Popov AY; Sadritdinova AF; Abramov IS; Kharitonov SL; Krasnov GS; Klimina KM; Koroban NV; Volchenko NN; Nyushko KM; Melnikova NV; Chernichenko MA; Sidorov DV; Alekseev BY; Kiseleva MV; Kaprin AD; Dmitriev AA; Snezhkina AV
BMC Genomics; 2018 Feb; 19(Suppl 3):113. PubMed ID: 29504907
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of NETO2 gene in colorectal cancer.
Fedorova MS; Snezhkina AV; Pudova EA; Abramov IS; Lipatova AV; Kharitonov SL; Sadritdinova AF; Nyushko KM; Klimina KM; Belyakov MM; Slavnova EN; Melnikova NV; Chernichenko MA; Sidorov DV; Kiseleva MV; Kaprin AD; Alekseev BY; Dmitriev AA; Kudryavtseva AV
BMC Genet; 2017 Dec; 18(Suppl 1):117. PubMed ID: 29297384
[TBL] [Abstract][Full Text] [Related]
3. Genomics and prognosis analysis of epithelial-mesenchymal transition in colorectal cancer patients.
Zhang Z; Zheng S; Lin Y; Sun J; Ding N; Chen J; Zhong J; Shi L; Xue M
BMC Cancer; 2020 Nov; 20(1):1135. PubMed ID: 33228590
[TBL] [Abstract][Full Text] [Related]
4. SPP1, analyzed by bioinformatics methods, promotes the metastasis in colorectal cancer by activating EMT pathway.
Xu C; Sun L; Jiang C; Zhou H; Gu L; Liu Y; Xu Q
Biomed Pharmacother; 2017 Jul; 91():1167-1177. PubMed ID: 28531945
[TBL] [Abstract][Full Text] [Related]
5. Lipocalin 2 negatively regulates cell proliferation and epithelial to mesenchymal transition through changing metabolic gene expression in colorectal cancer.
Kim SL; Lee ST; Min IS; Park YR; Lee JH; Kim DG; Kim SW
Cancer Sci; 2017 Nov; 108(11):2176-2186. PubMed ID: 28859238
[TBL] [Abstract][Full Text] [Related]
6.
Martinou E; Moller-Levet C; Karamanis D; Bagwan I; Angelidi AM
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216396
[TBL] [Abstract][Full Text] [Related]
7. LncRNA CHRF-induced miR-489 loss promotes metastasis of colorectal cancer via TWIST1/EMT signaling pathway.
Tao Y; Han T; Zhang T; Ma C; Sun C
Oncotarget; 2017 May; 8(22):36410-36422. PubMed ID: 28430582
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-200c modulates epithelial-to-mesenchymal transition (EMT) in human colorectal cancer metastasis.
Hur K; Toiyama Y; Takahashi M; Balaguer F; Nagasaka T; Koike J; Hemmi H; Koi M; Boland CR; Goel A
Gut; 2013 Sep; 62(9):1315-26. PubMed ID: 22735571
[TBL] [Abstract][Full Text] [Related]
9. Effect of lentivirus-mediated shRNA inactivation of HK1, HK2, and HK3 genes in colorectal cancer and melanoma cells.
Kudryavtseva AV; Fedorova MS; Zhavoronkov A; Moskalev AA; Zasedatelev AS; Dmitriev AA; Sadritdinova AF; Karpova IY; Nyushko KM; Kalinin DV; Volchenko NN; Melnikova NV; Klimina KM; Sidorov DV; Popov AY; Nasedkina TV; Kaprin AD; Alekseev BY; Krasnov GS; Snezhkina AV
BMC Genet; 2016 Dec; 17(Suppl 3):156. PubMed ID: 28105937
[TBL] [Abstract][Full Text] [Related]
10. NUBPL, a novel metastasis-related gene, promotes colorectal carcinoma cell motility by inducing epithelial-mesenchymal transition.
Wang Y; Wu N; Sun D; Sun H; Tong D; Liu D; Pang B; Li S; Wei J; Dai J; Liu Y; Bai J; Geng J; Fu S; Jin Y
Cancer Sci; 2017 Jun; 108(6):1169-1176. PubMed ID: 28346728
[TBL] [Abstract][Full Text] [Related]
11. Presence of Twist1-positive neoplastic cells in the stroma of chromosome-unstable colorectal tumors.
Celesti G; Di Caro G; Bianchi P; Grizzi F; Basso G; Marchesi F; Doni A; Marra G; Roncalli M; Mantovani A; Malesci A; Laghi L
Gastroenterology; 2013 Sep; 145(3):647-57.e15. PubMed ID: 23684708
[TBL] [Abstract][Full Text] [Related]
12. LncRNA TUG1 promoted KIAA1199 expression via miR-600 to accelerate cell metastasis and epithelial-mesenchymal transition in colorectal cancer.
Sun J; Hu J; Wang G; Yang Z; Zhao C; Zhang X; Wang J
J Exp Clin Cancer Res; 2018 May; 37(1):106. PubMed ID: 29776371
[TBL] [Abstract][Full Text] [Related]
13. The long non-coding RNA TUG1 indicates a poor prognosis for colorectal cancer and promotes metastasis by affecting epithelial-mesenchymal transition.
Sun J; Ding C; Yang Z; Liu T; Zhang X; Zhao C; Wang J
J Transl Med; 2016 Feb; 14():42. PubMed ID: 26856330
[TBL] [Abstract][Full Text] [Related]
14. ZEB2-AS1 Accelerates Epithelial/Mesenchymal Transition Through miR-1205/CRKL Pathway in Colorectal Cancer.
Jiang Y; Liu G; Ye W; Xie J; Shao C; Wang X; Li X
Cancer Biother Radiopharm; 2020 Mar; 35(2):153-162. PubMed ID: 31755734
[No Abstract] [Full Text] [Related]
15. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
[TBL] [Abstract][Full Text] [Related]
16. Short hairpin RNA- mediated gene knockdown of FOXM1 inhibits the proliferation and metastasis of human colon cancer cells through reversal of epithelial-to-mesenchymal transformation.
Yang K; Jiang L; Hu Y; Yu J; Chen H; Yao Y; Zhu X
J Exp Clin Cancer Res; 2015 May; 34(1):40. PubMed ID: 25935853
[TBL] [Abstract][Full Text] [Related]
17. Loss of profilin 2 contributes to enhanced epithelial-mesenchymal transition and metastasis of colorectal cancer.
Zhang H; Yang W; Yan J; Zhou K; Wan B; Shi P; Chen Y; He S; Li D
Int J Oncol; 2018 Sep; 53(3):1118-1128. PubMed ID: 30015842
[TBL] [Abstract][Full Text] [Related]
18. Role of SSH1 in colorectal cancer prognosis and tumor progression.
Song X; Xie D; Xia X; Tan F; Pei Q; Li Y; Zhou Z; Zhou Y; Li C; Wang K; Pei H
J Gastroenterol Hepatol; 2020 Jul; 35(7):1180-1188. PubMed ID: 32020663
[TBL] [Abstract][Full Text] [Related]
19. PDGF-D promotes cell growth, aggressiveness, angiogenesis and EMT transformation of colorectal cancer by activation of Notch1/Twist1 pathway.
Chen J; Yuan W; Wu L; Tang Q; Xia Q; Ji J; Liu Z; Ma Z; Zhou Z; Cheng Y; Shu X
Oncotarget; 2017 Feb; 8(6):9961-9973. PubMed ID: 28035069
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of ZEB2 at the invasion front of colorectal cancer is an independent prognostic marker and regulates tumor invasion in vitro.
Kahlert C; Lahes S; Radhakrishnan P; Dutta S; Mogler C; Herpel E; Brand K; Steinert G; Schneider M; Mollenhauer M; Reissfelder C; Klupp F; Fritzmann J; Wunder C; Benner A; Kloor M; Huth C; Contin P; Ulrich A; Koch M; Weitz J
Clin Cancer Res; 2011 Dec; 17(24):7654-63. PubMed ID: 22042972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]